CD163 and melanoma: Result showed there was no significant difference between the expression of CD163 in low risk score and high risk score group of macrophages (p=0.25) (Figure S15B), suggesting that the characteristic of these high risk score macrophages in melanoma may be not fully same as M2 macrophage subpopulation (29).